In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis

Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta parasitologica 2020-03, Vol.65 (1), p.203-207
Hauptverfasser: da Silva, Emerson Teixeira, de Andrade, Gabriel Fernandes, Araújo, Adriele da Silva, Almeida, Ayla das Chagas, Coimbra, Elaine S., de Souza, Marcus Vinícius Nora
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 207
container_issue 1
container_start_page 203
container_title Acta parasitologica
container_volume 65
creator da Silva, Emerson Teixeira
de Andrade, Gabriel Fernandes
Araújo, Adriele da Silva
Almeida, Ayla das Chagas
Coimbra, Elaine S.
de Souza, Marcus Vinícius Nora
description Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against Leishmania amazonensis . Methods The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of Leishmania amazonensis , and murine macrophages. Results The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC 50 values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC 50 (21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of Leishmania amazonensis 2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC 50  = 41.17 µM, 1.9 times less active than the reference drug (IC 50  = 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages. Conclusions Most compounds showed activity against amastigote form of Leishmania amazonensis, being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.
doi_str_mv 10.2478/s11686-019-00146-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2383815595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2383815595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMo3l_AhQRcj-YykybLUq9QcKPrcDI9bac4mZozLejTm7ZedkIgt-__D3yMXUhxrcqBvSEpjTWFkK4QQpamqPbYsbTOFNJWcj-flRaFskoesROihRClsdYesiMtrVZOyWPmnyJfN33q-JAIiVqMPe-mfATtct4l_vgxSfDZReS3mJo19M0aiUNekQ9nG3g4gyZSz8fY0LyF2ACHdhuJ1NAZO5jCG-H5937KXu_vXkaPxfj54Wk0HBe1HlR9UZcGJLgSSqgnaopVEBMZagza1rUYIAYHzuRnJ1wIwQIE62y-lGjqyqA-ZVe73mXq3ldIvV90qxTzSK-01VZWlasypXZUnTqihFO_TE0L6cNL4TdO_c6pz0791qnfhC6_q1ehxclv5EdiBvQOoPwVZ5j-Zv9T-wVr84Om</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2383815595</pqid></control><display><type>article</type><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</creator><creatorcontrib>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</creatorcontrib><description>Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against Leishmania amazonensis . Methods The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of Leishmania amazonensis , and murine macrophages. Results The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC 50 values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC 50 (21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of Leishmania amazonensis 2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC 50  = 41.17 µM, 1.9 times less active than the reference drug (IC 50  = 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages. Conclusions Most compounds showed activity against amastigote form of Leishmania amazonensis, being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</description><identifier>ISSN: 1230-2821</identifier><identifier>EISSN: 1896-1851</identifier><identifier>DOI: 10.2478/s11686-019-00146-5</identifier><identifier>PMID: 31832921</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Amastigotes ; Animal Systematics/Taxonomy/Biogeography ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Camphor ; Camphor - chemistry ; Camphor - pharmacology ; Cytotoxicity ; Derivatives ; Drug development ; Drug Discovery ; Drugs ; Ecology ; Evaluation ; Female ; Hydrazones ; Hydrazones - chemical synthesis ; Hydrazones - pharmacology ; Inhibitory Concentration 50 ; Intracellular ; Leishmania amazonensis ; Leishmania mexicana - drug effects ; Leishmania mexicana - growth &amp; development ; Leishmaniasis ; Life Cycle Stages ; Macrophages ; Macrophages - drug effects ; Macrophages - parasitology ; Medical Microbiology ; Mice ; Mice, Inbred BALB C ; Microbiology ; Miltefosine ; Original Paper ; Parasites ; Parasitic diseases ; Parasitology ; Selectivity ; Vector-borne diseases</subject><ispartof>Acta parasitologica, 2020-03, Vol.65 (1), p.203-207</ispartof><rights>Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019</rights><rights>Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</citedby><cites>FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</cites><orcidid>0000-0003-1566-8110</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.2478/s11686-019-00146-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.2478/s11686-019-00146-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31832921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Emerson Teixeira</creatorcontrib><creatorcontrib>de Andrade, Gabriel Fernandes</creatorcontrib><creatorcontrib>Araújo, Adriele da Silva</creatorcontrib><creatorcontrib>Almeida, Ayla das Chagas</creatorcontrib><creatorcontrib>Coimbra, Elaine S.</creatorcontrib><creatorcontrib>de Souza, Marcus Vinícius Nora</creatorcontrib><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><title>Acta parasitologica</title><addtitle>Acta Parasit</addtitle><addtitle>Acta Parasitol</addtitle><description>Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against Leishmania amazonensis . Methods The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of Leishmania amazonensis , and murine macrophages. Results The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC 50 values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC 50 (21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of Leishmania amazonensis 2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC 50  = 41.17 µM, 1.9 times less active than the reference drug (IC 50  = 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages. Conclusions Most compounds showed activity against amastigote form of Leishmania amazonensis, being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</description><subject>Amastigotes</subject><subject>Animal Systematics/Taxonomy/Biogeography</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Camphor</subject><subject>Camphor - chemistry</subject><subject>Camphor - pharmacology</subject><subject>Cytotoxicity</subject><subject>Derivatives</subject><subject>Drug development</subject><subject>Drug Discovery</subject><subject>Drugs</subject><subject>Ecology</subject><subject>Evaluation</subject><subject>Female</subject><subject>Hydrazones</subject><subject>Hydrazones - chemical synthesis</subject><subject>Hydrazones - pharmacology</subject><subject>Inhibitory Concentration 50</subject><subject>Intracellular</subject><subject>Leishmania amazonensis</subject><subject>Leishmania mexicana - drug effects</subject><subject>Leishmania mexicana - growth &amp; development</subject><subject>Leishmaniasis</subject><subject>Life Cycle Stages</subject><subject>Macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - parasitology</subject><subject>Medical Microbiology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microbiology</subject><subject>Miltefosine</subject><subject>Original Paper</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Parasitology</subject><subject>Selectivity</subject><subject>Vector-borne diseases</subject><issn>1230-2821</issn><issn>1896-1851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMo3l_AhQRcj-YykybLUq9QcKPrcDI9bac4mZozLejTm7ZedkIgt-__D3yMXUhxrcqBvSEpjTWFkK4QQpamqPbYsbTOFNJWcj-flRaFskoesROihRClsdYesiMtrVZOyWPmnyJfN33q-JAIiVqMPe-mfATtct4l_vgxSfDZReS3mJo19M0aiUNekQ9nG3g4gyZSz8fY0LyF2ACHdhuJ1NAZO5jCG-H5937KXu_vXkaPxfj54Wk0HBe1HlR9UZcGJLgSSqgnaopVEBMZagza1rUYIAYHzuRnJ1wIwQIE62y-lGjqyqA-ZVe73mXq3ldIvV90qxTzSK-01VZWlasypXZUnTqihFO_TE0L6cNL4TdO_c6pz0791qnfhC6_q1ehxclv5EdiBvQOoPwVZ5j-Zv9T-wVr84Om</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>da Silva, Emerson Teixeira</creator><creator>de Andrade, Gabriel Fernandes</creator><creator>Araújo, Adriele da Silva</creator><creator>Almeida, Ayla das Chagas</creator><creator>Coimbra, Elaine S.</creator><creator>de Souza, Marcus Vinícius Nora</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0003-1566-8110</orcidid></search><sort><creationdate>20200301</creationdate><title>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</title><author>da Silva, Emerson Teixeira ; de Andrade, Gabriel Fernandes ; Araújo, Adriele da Silva ; Almeida, Ayla das Chagas ; Coimbra, Elaine S. ; de Souza, Marcus Vinícius Nora</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c46a1a94a4acd2fe5b0d1bceb38cc07eeb9a96e5b909bbb8aab8989094e6c56e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amastigotes</topic><topic>Animal Systematics/Taxonomy/Biogeography</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Camphor</topic><topic>Camphor - chemistry</topic><topic>Camphor - pharmacology</topic><topic>Cytotoxicity</topic><topic>Derivatives</topic><topic>Drug development</topic><topic>Drug Discovery</topic><topic>Drugs</topic><topic>Ecology</topic><topic>Evaluation</topic><topic>Female</topic><topic>Hydrazones</topic><topic>Hydrazones - chemical synthesis</topic><topic>Hydrazones - pharmacology</topic><topic>Inhibitory Concentration 50</topic><topic>Intracellular</topic><topic>Leishmania amazonensis</topic><topic>Leishmania mexicana - drug effects</topic><topic>Leishmania mexicana - growth &amp; development</topic><topic>Leishmaniasis</topic><topic>Life Cycle Stages</topic><topic>Macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - parasitology</topic><topic>Medical Microbiology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microbiology</topic><topic>Miltefosine</topic><topic>Original Paper</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Parasitology</topic><topic>Selectivity</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Emerson Teixeira</creatorcontrib><creatorcontrib>de Andrade, Gabriel Fernandes</creatorcontrib><creatorcontrib>Araújo, Adriele da Silva</creatorcontrib><creatorcontrib>Almeida, Ayla das Chagas</creatorcontrib><creatorcontrib>Coimbra, Elaine S.</creatorcontrib><creatorcontrib>de Souza, Marcus Vinícius Nora</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Acta parasitologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Emerson Teixeira</au><au>de Andrade, Gabriel Fernandes</au><au>Araújo, Adriele da Silva</au><au>Almeida, Ayla das Chagas</au><au>Coimbra, Elaine S.</au><au>de Souza, Marcus Vinícius Nora</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis</atitle><jtitle>Acta parasitologica</jtitle><stitle>Acta Parasit</stitle><addtitle>Acta Parasitol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>65</volume><issue>1</issue><spage>203</spage><epage>207</epage><pages>203-207</pages><issn>1230-2821</issn><eissn>1896-1851</eissn><abstract>Purpose Due to serious problems with the treatment of leishmaniasis all around the world, here is an urgent need in the search for new drugs that are more effective and safer for the treatment of the various forms of leishmaniasis. Actual therapy is limited and lacks sufficient efficacy due to incomplete elimination of the parasites form of patients. In this sense, we decided to evaluate, by first-time, a series of seventeen camphor hydrazone derivatives (2a–2p) against Leishmania amazonensis . Methods The compounds previously synthesized from camphor, an abundant natural compound, were evaluated in vitro against the extra and intracellular forms of Leishmania amazonensis , and murine macrophages. Results The majority of compounds, fourteen, displayed activity against the intracellular form of the parasite (amastigote) with IC 50 values ranging from 21.78 to 58.23 µM, being six compounds active for both forms of the parasite. The compound 2i exhibited higher activity against the amastigote form with the value of IC 50 (21.78 µM) close to standard utilized miltefosine (12.74 µM) and selectivity index of at least 6.9. Six compounds displayed activity against promastigote form of Leishmania amazonensis 2g, 2j–2n (41.17–69.59 µM), with the compound 2m being the more active with IC 50  = 41.17 µM, 1.9 times less active than the reference drug (IC 50  = 21.39 µM). The compound 2m was the more selective to this form, with a selectivity index of at least 3.6. All the compounds were non-cytotoxic to macrophages. Conclusions Most compounds showed activity against amastigote form of Leishmania amazonensis, being that they were not cytotoxic to macrophage at the maximum tested concentration, showing the selective property of these compounds. Since amastigotes are the parasite stages that cause the disease in humans, these results highlight the antileishmanial effect of the compounds. This study indicates the possible development of candidates to leishmanicidal drugs from an abundant natural compound of easy access.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31832921</pmid><doi>10.2478/s11686-019-00146-5</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-1566-8110</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1230-2821
ispartof Acta parasitologica, 2020-03, Vol.65 (1), p.203-207
issn 1230-2821
1896-1851
language eng
recordid cdi_proquest_journals_2383815595
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Amastigotes
Animal Systematics/Taxonomy/Biogeography
Animals
Biomedical and Life Sciences
Biomedicine
Camphor
Camphor - chemistry
Camphor - pharmacology
Cytotoxicity
Derivatives
Drug development
Drug Discovery
Drugs
Ecology
Evaluation
Female
Hydrazones
Hydrazones - chemical synthesis
Hydrazones - pharmacology
Inhibitory Concentration 50
Intracellular
Leishmania amazonensis
Leishmania mexicana - drug effects
Leishmania mexicana - growth & development
Leishmaniasis
Life Cycle Stages
Macrophages
Macrophages - drug effects
Macrophages - parasitology
Medical Microbiology
Mice
Mice, Inbred BALB C
Microbiology
Miltefosine
Original Paper
Parasites
Parasitic diseases
Parasitology
Selectivity
Vector-borne diseases
title In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A52%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20Assessment%20of%20Camphor%20Hydrazone%20Derivatives%20as%20an%20Agent%20Against%20Leishmania%20amazonensis&rft.jtitle=Acta%20parasitologica&rft.au=da%20Silva,%20Emerson%20Teixeira&rft.date=2020-03-01&rft.volume=65&rft.issue=1&rft.spage=203&rft.epage=207&rft.pages=203-207&rft.issn=1230-2821&rft.eissn=1896-1851&rft_id=info:doi/10.2478/s11686-019-00146-5&rft_dat=%3Cproquest_cross%3E2383815595%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2383815595&rft_id=info:pmid/31832921&rfr_iscdi=true